News

Dr. Plancher Appointed Lead Investigator For Episurf’s Episealer® IDE study

Episurf Medical AB

Episurf Medical AB (Nasdaq: EPIS B) announces that Dr. Kevin D. Plancher, MD, MPH of Plancher Orthopaedics & Sport Medicine, New York, has been appointed Lead Investigator for the company’s IDE clinical study, EPIC-Knee: Episealer® Knee System IDE Clinical Study. As Lead Investigator, Dr. Plancher will serve as a medical advisor to Episurf Medical and the other sites and investigators for any trial-related questions. Dr. Plancher will also be one of the surgeons performing surgeries in the clinical trial.

Read More >>

Related Post

Kevin D. Plancher, MD, MPH, FAOA, FAOS & Orthopaedic Foundation Research
14May

Kevin D. Plancher, MD, MPH, FAOA, FAOS & Orthopaedic Foundation Research

Article PublishedNew York and Greenwich, CTMay 14, 2024 Journal of Orthopaedics for Physician Assistants recently published the article Management of…

Kevin D. Plancher, MD, MPH, FAOA, FAOS Attends ESSKA 2024
13May

Kevin D. Plancher, MD, MPH, FAOA, FAOS Attends ESSKA 2024

New York and Greenwich, CT May 13, 2024 Dr. Kevin Plancher attended the 21st ESSKA Congress this week in Milan,…

Kevin D. Plancher, MD, MPH, FAOA, FAOS Ranked Top 1%
07May

Kevin D. Plancher, MD, MPH, FAOA, FAOS Ranked Top 1%

New York and Greenwich, CT May 7, 2024 Dr. Kevin Plancher is pleased to announce the recent recognition as one…